Uncategorized Day One Biopharmaceuticals’ (DAWN) “Buy” Rating Reiterated at Needham & Company LLC otakuyassine3@gmail.com Jan 13, 2025 Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report)‘s stock had its “buy” rating reissued by...